Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BDNF Val66Met genotype and 6-month remission rates in late-life depression.

The pharmacogenomics journal - 1 Apr 2011

Taylor W D, McQuoid D R, Ashley-Koch A, MacFall J R, Bridgers J, Krishnan R R, Steffens D C

Abstract excerpt

Although not observed in younger adult cohorts, in older individuals the brain-derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with major depressive disorder (MDD) risk. It is further associated with subjective social support and magnetic resonance imaging (MRI) hyperintense lesions, clinical features independently related to MDD. We examined the relationship between this polymorphism and...

Topics

Join the communities discussing this publication.

Amino Acid Substitution
Brain-Derived Neurotrophic Factor
Depressive Disorder, Major
Methionine
Point Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Remission Induction

Source

Open in PubMed Open full text

Identifiers

PMID: 20195291
DOI: 10.1038/tpj.2010.12
PMCID: PMC2962689

Genes

BDNF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BDNF Val66Met genotype and 6-month remission rates in late-life depression.PMID 20195291Read ↗

Brain-derived neurotrophic factor Val66Met polymorphism and 6-month antidepressant remission in depressed Caucasian patients.Semantic proximity Read ↗

BDNF val66met polymorphism, white matter abnormalities and remission of geriatric depression.Semantic proximity Read ↗

Brain-derived neurotrophic factor Val66Met polymorphism and remission after antidepressant treatment in depressed Caucasian patients: a meta-analysis.Semantic proximity Read ↗

Allelic differences in the brain-derived neurotrophic factor Val66Met polymorphism in late-life depression.Semantic proximity Read ↗

Plasma BDNF Level in Major Depression: Biomarker of the Val66Met BDNF Polymorphism and of the Clinical Course in Met Carrier Patients.Semantic proximity Read ↗

Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.Semantic proximity Read ↗

Association of serum BDNF level and Val66Met polymorphism with response to treatment in patients of major depressive disease: A step towards personalized therapy.Semantic proximity Read ↗

The brain-derived neurotrophic factor VAL66MET polymorphism and cerebral white matter hyperintensities in late-life depression.Semantic proximity Read ↗

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.Semantic proximity Read ↗

Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.Semantic proximity Read ↗

Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome.Semantic proximity Read ↗

The brain-derived neurotrophic-factor (BDNF) val66met polymorphism is associated with geriatric depression: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.